These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 35663995)

  • 1. Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Tu J; Jin J; Chen X; Sun L; Cai Z
    Front Immunol; 2022; 13():868983. PubMed ID: 35663995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate Genes Identified in Systemic Sclerosis-Related Pulmonary Arterial Hypertension Were Associated with Immunity, Inflammation, and Cytokines.
    Xu Z; Ruan J; Pan L; Chen C
    Cardiovasc Ther; 2021; 2021():6651009. PubMed ID: 33680092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis.
    Zhang T; Huang C; Luo H; Li J; Huang H; Liu X; Zhan S
    Life Sci; 2021 Apr; 271():119151. PubMed ID: 33539912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of TFRC as a biomarker for pulmonary arterial hypertension based on bioinformatics and experimental verification.
    Yang C; Liu YH; Zheng HK
    Respir Res; 2024 Aug; 25(1):296. PubMed ID: 39097701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of CDKN1A and HDAC1 as Senescence-Related Hub Genes in Chronic Obstructive Pulmonary Disease.
    Yang J; Zhang MY; Du YM; Ji XL; Qu YQ
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1811-1825. PubMed ID: 35975032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension.
    Lian G; You J; Lin W; Gao G; Xu C; Wang H; Luo L
    BMC Pulm Med; 2023 Aug; 23(1):300. PubMed ID: 37582718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis.
    Wu W; Chen A; Lin S; Wang Q; Lian G; Luo L; Xie L
    BMC Pulm Med; 2022 Dec; 22(1):474. PubMed ID: 36514015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis.
    Zeng Y; Li N; Zheng Z; Chen R; Liu W; Cheng J; Zhu J; Zeng M; Peng M; Hong C
    Bioengineered; 2021 Dec; 12(1):2576-2591. PubMed ID: 34233597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis.
    Xu B; Xu G; Yu Y; Lin J
    Arthritis Res Ther; 2021 Nov; 23(1):288. PubMed ID: 34819148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Key Genes Associated With Systemic Sclerosis-Related Pulmonary Hypertension.
    Zheng JN; Li Y; Yan YM; Shi H; Zou TT; Shao WQ; Wang Q
    Front Genet; 2020; 11():816. PubMed ID: 32793290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel biomarkers involved in pulmonary arterial hypertension based on multiple-microarray analysis.
    Ma Y; Chen SS; Feng YY; Wang HL
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32886110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension.
    Tang S; Liu Y; Liu B
    Sci Rep; 2022 Jun; 12(1):10154. PubMed ID: 35710932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression profiling of microRNA in systemic sclerosis-associated pulmonary arterial hypertension.
    Huang YX; Li F; Liu D; Sun YY; Zhao QH; Jiang R; Wang L; Yuan P; Liu JM; Wu Y; Zhang J
    Ann Transl Med; 2021 Sep; 9(18):1458. PubMed ID: 34734010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate genes in scleroderma-related pulmonary arterial hypertension.
    Grigoryev DN; Mathai SC; Fisher MR; Girgis RE; Zaiman AL; Housten-Harris T; Cheadle C; Gao L; Hummers LK; Champion HC; Garcia JG; Wigley FM; Tuder RM; Barnes KC; Hassoun PM
    Transl Res; 2008 Apr; 151(4):197-207. PubMed ID: 18355767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.
    Christmann RB; Hayes E; Pendergrass S; Padilla C; Farina G; Affandi AJ; Whitfield ML; Farber HW; Lafyatis R
    Arthritis Rheum; 2011 Jun; 63(6):1718-28. PubMed ID: 21425123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and Identification of Therapeutic Targets for Pulmonary Arterial Hypertension Through Microarray Technology.
    Li Q; Meng L; Liu D
    Front Genet; 2020; 11():782. PubMed ID: 32849793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
    Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension.
    He W; Su X; Chen L; Liu C; Lu W; Wang T; Wang J
    Physiol Rep; 2022 Jan; 10(1):e15101. PubMed ID: 34981661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signal recognition particle-related joint model of LASSO regression, SVM-RFE and artificial neural network for the diagnosis of systemic sclerosis-associated pulmonary hypertension.
    Xu J; Liang C; Li J
    Front Genet; 2022; 13():1078200. PubMed ID: 36518216
    [No Abstract]   [Full Text] [Related]  

  • 20. Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
    Seki N; Tsujimoto H; Tanemura S; Ishigaki S; Takei H; Sugahara K; Yoshimoto K; Akiyama M; Kaneko Y; Chiba K; Takeuchi T
    Cytokine; 2024 Apr; 176():156534. PubMed ID: 38354516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.